Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Human brucellosis: sero-prevalence and associated risk factors in agro-pastoral communities of Kiboga District, Central Uganda

Authors: Gabriel Tumwine, Enock Matovu, John David Kabasa, David Okello Owiny, Samuel Majalija

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Brucellosis remains a neglected zoonotic disease among agro-pastoral communities where unprocessed milk and milk products are consumed. A cross-sectional study was carried out in Kiboga district to determine the seroprevalence and risk factors associated with human brucellosis in communities where livestock rearing in a common practice.

Methods

A total of 235 participants were involved in the study. Blood samples from the participants were collected and screened for Brucella using Serum Agglutination Test and Rose Bengal Plate Test. A questionnaire was used to collect data on socio-demographic characteristics and human brucellosis related risk factors.

Results

Human Brucella seroprevalence was at 17.0 % (n = 235). The prevalence was highest among males (20.5 %, n = 78) and the elderly - above 60 years (22.2 %, n = 18). Residence in rural areas (OR 3.16, 95 % CI: 1.16–8.56), consuming locally processed milk products (OR 2.54, 95 % CI: 1.12–5.78) and being single (OR 2.44, 95 % CI: 1.05–5.68), were associated with increased risk of brucellosis.

Discussion

Human brucellosis seroprevalence was high at 17 %, this was parallel with animal brucellosis prevalence that has been reported to range from 10.2 % to 25.7 % in cattle in the region. The participants were from communities known to habitually consume raw milk and milk products, know to process milk products using bare hands which are major risk factors for brucellosis in humans. This also explains why consumption of unpasteurized milk products was associated with the occurrence of brucellosis in study area. This strengthened the argument that humans get infected through consumption of contaminated animal products as reported in other earlier studies. Males and elderly being more affected because of traditional roles of these groups they play in livestock care and management. The single were also to be more associated to brucellosis, due to the fact that this group consume milk and milk products more as it is readily available in the informal markets as highly nutritious fast foods in this community as also observed in USA.

Conclusions

Brucellosis is highly prevalent in Kiboga district, and therefore, an important public health problem. The transmission risk was aggravated by consumption of unpasteurized milk products, residing in rural settings and being single. There is a need to initiate screening, treat infected humans early, and educate the public about risk factors and appropriate preventive measures of brucellosis.
Literature
1.
2.
3.
Makita K, Eric FM, Waiswa C, Kaboyo W, Mark EC, Susan WC. Spatial epidemiology of hospital-diagnosed brucellosis in Kampala, Uganda. Int J Health Geogr. 2011;10:52.CrossRefPubMedPubMedCentral
4.
Godfroid J, Scholz HC, Barbier T, Niclas C, Wattiau P, Fretin D, et al. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Prev Vet Med. 2011;1–14.
5.
Makita K, Fevre EM, Waiswa C, Kaboyo W, De Clare Bronsvoort BM, Eisler MC, et al. Human brucellosis in urban and peri-urban areas of Kampala, Uganda. Animal Biodiversity and Emerging Diseases. Prediction and Prevention. 2008;1149:309–11.
6.
7.
Abdussalam M, Fein DA. Brucellosis as a world problem. Dev Biol Stand. 1976;31:9–23.PubMed
8.
9.
Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, Walravens K, et al. From the discovery of the Malta fever’s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005;36:313–26.CrossRefPubMed
10.
Kunda J, Fitzpatrick J, Kazwala R, French NP, Shirima G, et al. Health-seeking behaviour of human brucellosis cases in rural Tanzania. BMC Public Health. 2007;7:315.CrossRefPubMedPubMedCentral
11.
McDermont JJ, Arimi SM. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet Microbiol. 2002;20:111–34.CrossRef
12.
Mutanda LN. Selected laboratory tests in febrile patients in Kampala, Uganda. East Afr Med J. 1998;75:68–72.PubMed
13.
Dames S, Tonnerre C, Saint S, Jones SR. Clinical problem-solving. Don’t know much about history. N Engl J Med. 2005;352:2338–42.CrossRefPubMed
14.
Andriopoulos P, Tsironi M, Deftereos S, Aessopos A, Assimakopoulos G. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis. 2007;11:52–7.CrossRefPubMed
15.
Bingöl A, Yücemen N, Meço O. Medically treated intraspinal “Brucella” granuloma. Surg Neurol. 1999;52:570–6.CrossRefPubMed
16.
María Pía F, Maximilian M, Gilman RH, Smits HL. Human brucellosis, Review. Lancet Infect Dis. 2007;7:775–86.CrossRef
17.
Uddin MJ, Sanyal SC, Mustafa AS, et al. The role of aggressive medical therapy along with early surgical intervention in the cure of Brucella endocarditis. Ann Thorac Cardiovasc Surg. 1998;4:209–13.PubMed
18.
19.
Roop RM, Gaines JM, Anderson ES, Caswell CC, Martin DW. Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host. Med Microbiol Immunol. 2009;198:221–38.CrossRefPubMed
20.
Franco MP, Mulder M, Gilman RH, Smits HL. Review: Human Brucellosis. Lancet Infect Dis. 2007;7:775–86.CrossRefPubMed
21.
Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91–9.CrossRefPubMed
22.
Mangen MJ, Otte J, Pfeiffer D, Chilonda P. Bovine brucellosis in Sub Saharan Africa. Estimation of seroprevalence and impact on meat and milk off take potential, Livestock Policy Discussion Paper No. 8. FAO Livestock Information and Policy Branch, AGA. Available www.​fao.​org/​3/​a-ag274e.​pdf (Accessed on 29/06/2014). 2002.
23.
Swai ES, Schoonman L. Human brucellosis: seroprevalence and risk factors related to high risk occupational groups in Tanga Municipality, Tanzania. Zoonoses Public Health. 2009;56:183–7.CrossRefPubMed
24.
25.
26.
Makita K, Eric FM, Waiswa C, Mark EC, Thrusfield M, Susan WC. Herd prevalence of bovine brucellosis and analysis of risk factors in cattle in urban and peri-urban areas of the Kampala economic zone, Uganda. BMC Vet Res. 2011;7:1–8.CrossRef
27.
Egaru D, Zirintunda G, Ekou J. Seroprevalence of brucellosis in cattle of Arapai Sub-County of Soroti, Uganda. J Exp Biol Agric Sci. 2013;1:1–6.
28.
Mugabi R. Brucellosis epidemiology, virulence factors, control and molecular targets to prevent bacterial infectious diseases. Masters thesis, submitted to the Graduate Faculty of the North Dakota State University of Agriculture and Applied Science. 2012.
29.
Nabukenya I, Kaddu-Mulindwa D, Nasinyama GW. Survey of Brucella infection and malaria among Abattoir workers in Kampala and Mbarara Districts, Uganda. BMC Public Health. 2013;13:901.CrossRefPubMedPubMedCentral
30.
Hartigan P. Human brucellosis: epidemiology and clinical manifestations. Ir Vet J. 1997;50:179–80.
31.
Staal SJ, Kaguongo WN. The Ugandan dairy subsector targeting development opportunities. Nairobi, Kenya: International Livestock Research Institute (ILRI); 2003.
32.
Kunda J, Fitzpatrick J, Kazwala R, French NP, Shirima G, MacMillan A, et al. Health-seeking behaviour of human brucellosis cases in rural Tanzania. BMC Public Health. 2007;7:315.CrossRefPubMedPubMedCentral
33.
34.
UBOS/MAAIF. Summary report of the national livestock census 2008. Kampala, Uganda: Uganda Bureau of Statistics/Ministry of Agriculture Animal Industry and Fisheries; 2009.
35.
Martin SW, Meek AH, Willeberg P. Veterinary epidemiology; principles and methods. Ames: Iowa State Univesrity Press; 1987. p. 31–46.
36.
Alton GG, Jones LM, Angus RD, Verger JM. Serological methods. In: Alton GG, editor. Techniques for the brucellosis laboratory. Paris, France: Institute National de la Recherche Agronomique; 1988.
37.
Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis-a review of the literature. Part II: serological tests for brucellosis. Clin Lab. 2003;49:577–89.PubMed
38.
39.
Ruiz-Mesa JD, Sanchez-Gonzalez J, Reguera JM, Martin L, Lopez-Palmero S, Colmenero JD. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect. 2005;11:221–5.CrossRefPubMed
40.
Kohei M, Eric FM, Charles W, Mark EC, Susan WC. How human brucellosis incidence in urban Kampala can be reduced most efficiently? A stochastic risk assessment of informally-marketed milk. PLoS ONE. 2010;5(12):1–10.
41.
Maichomo MW, McDermott JJ, Arimi SM, Gathura PB, Mugambi TJ, Muriuki SM. Study of brucellosis in a pastoral community and evaluation of the usefulness of clinical signs and symptoms in differentiating it from other flu-like diseases. Afr J Health Sci. 2000;7(18):114–9.PubMed
42.
Muriuki SM, McDermott JJ, Arimi SM, Mugambi JT, Wamola IA. Criteria for better detection of brucellosis in the Narok district of Kenya. East Afr Med J. 1997;74:317–20.PubMed
43.
44.
Omore AO, Muriuki H, Kenyanjui M, Owango M, Staal SJ. The dairy sub-sector: a rapid appraisal: research report of the MoA/KARI/ILRI smallholder dairy project, Nairobi. Nairobi, Kenya: International Livestock Research Institute; 1999.
45.
46.
Masomeh S, Arezoo A, Ali Akbar V, Mohammad B, Ali E, Amitis R. Risk factors for human brucellosis in Iran: a case–control study. Int J Infect Dis. 2008;12:157–61.CrossRef
47.
Husseini AS, Ramlawi AM. Brucellosis in the West Bank, Palestine. Saudi Med J. 2004;25:1640–3.PubMed
48.
Kalaajieh WK. Epidemiology of human brucellosis in Lebanon in 1997. Med Mal Infect. 2000;30:43–6.CrossRef
49.
Elbeltagy K. An epidemiological profile of brucellosis in Tabuk Province, Saudi Arabia. East Mediterr Health J. 2001;7:790–8.
50.
Omore AO, Arimi SM, Kan’gethe E, McDermott JJ, Staal SJ, Ouma E, et al. Assessing and managing milkborne health risks for the benefit of consumers in Kenya. Nairobi: International Livestock Research Institute; 2002.
51.
Hendricks MK, Perez EM, Burger PJ, Mouton PA. Brucellosis in childhood in Western Cape. S Afr Med J. 1995;85:176–8.PubMed
52.
Cooper CW. Risk factors in transmission of brucellosis from animals to humans in Saudi Arabia. Trans R Soc Trop Med Hyg. 1992;86:206–9.CrossRefPubMed
53.
Kozukeev TB AS, Maes E, Favorov M, Centers for Disease, Control PC. Risk factors for brucellosis--Leylek and Kadamjay districts, Batken Oblast, Kyrgyzstan, January-November, 2003. MMWR Morb Mortal Wkly Rep. 2006;55 Suppl 1:31–4.
54.
Mishal J, Ben-Israel N, Levin Y, Sherf S, Jafari J, Embon E, et al. Brucellosis outbreak: analysis of risk factors and serologic screening. Int J Mol Med. 1999;4(6):655–8.PubMed
55.
Abdollahia A, Mortezab A, Khalilzadehb O, Rasoulinejad M. Brucellosis serology in HIV-infected patients. Int J Infect Dis. 2010;14(10):e904–6.CrossRef
56.
Rahman AK, Dirk B, Fretin D, Saegerman C, Ahmed MU, Muhammad N, et al. Seroprevalence and risk factors for brucellosis in a high-risk group of individuals in Bangladesh. Foodborne Pathog Dis. 2012;9:190–7.CrossRefPubMed
57.
Schelling E, Diguimbaye C, Daoud S, Nicolet J, Boerlin P, Tanner M, et al. Brucellosis and Q-fever seroprevalences of nomadic pastoralists and their livestock in Chad. Prev Vet Med. 2003;61(4):279–93.CrossRefPubMed
58.
Kunda J, Julie F, Nigel F, Rudovick K, Dominic K, Mfinanga GS, et al. Quantifying risk factors for human brucellosis in rural northern Tanzania. PLoS One. 2010;5(4):e9968.CrossRef
59.
Gur A, Geyik MF, Dikici B, Nas K, Cevik R, Sarac J, et al. Complications of brucellosis in different age groups: a study of 283 cases in Southeastern Anatolia of Turkey. Yonsei Med J. 2003;44:33–44.CrossRefPubMed
60.
Jennings GJ, Hajjeh RA, Girgis FY, Fadeel MA, Maksoud MA, Wasfy MO, et al. Brucellosis as a cause of acute febrile illness in Egypt. Trans R Soc Trop Med Hyg. 2007;101:707–13.CrossRefPubMed
61.
Alballa SR. Epidemiology of human brucellosis in southern Saudi Arabia. J Trop Med Hyg. 1995;98:185–9.PubMed
62.
Ayyaz S, Badar H, Ghafoor A. Level & determinants of consumers’ perception of packed milk in Pakistan. J Bus Econ. 2011;3:60–76.
63.
Metadata
Title
Human brucellosis: sero-prevalence and associated risk factors in agro-pastoral communities of Kiboga District, Central Uganda
Authors
Gabriel Tumwine
Enock Matovu
John David Kabasa
David Okello Owiny
Samuel Majalija
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-2242-z

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Study protocol

Rationale and methods for a randomized controlled trial of a movement-to-music video program for decreasing sedentary time among mother-child pairs

Research article

Type, frequency and purpose of information used to inform public health policy and program decision-making

Research article

Demographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009–2010

Research article

Reducing electronic media use in 2–3 year-old children: feasibility and efficacy of the Family@play pilot randomised controlled trial

Research article

Socioeconomic factors and other sources of variation in the prevalence of genital chlamydia infections: A systematic review and meta-analysis

Research article

Towards a physically more active lifestyle based on one’s own values: the results of a randomized controlled trial among physically inactive adults